202 related articles for article (PubMed ID: 11961407)
1. GLEPP1 receptor tyrosine phosphatase (Ptpro) in rat PAN nephrosis. A marker of acute podocyte injury.
Kim YH; Goyal M; Wharram B; Wiggins J; Kershaw D; Wiggins R
Nephron; 2002 Apr; 90(4):471-6. PubMed ID: 11961407
[TBL] [Abstract][Full Text] [Related]
2. Glomerular epithelial protein 1 and podocalyxin-like protein 1 in inflammatory glomerular disease (crescentic nephritis) in rabbit and man.
Yang DH; Goyal M; Sharif K; Kershaw D; Thomas P; Dysko R; Wiggins R
Lab Invest; 1996 Mar; 74(3):571-84. PubMed ID: 8600307
[TBL] [Abstract][Full Text] [Related]
3. Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate.
Wharram BL; Goyal M; Gillespie PJ; Wiggins JE; Kershaw DB; Holzman LB; Dysko RC; Saunders TL; Samuelson LC; Wiggins RC
J Clin Invest; 2000 Nov; 106(10):1281-90. PubMed ID: 11086029
[TBL] [Abstract][Full Text] [Related]
4. Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. A dedifferentiation hypothesis for the nephrotic syndrome.
Sharif K; Goyal M; Kershaw D; Kunkel R; Wiggins R
Exp Nephrol; 1998; 6(3):234-44. PubMed ID: 9639039
[TBL] [Abstract][Full Text] [Related]
5. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
Kawakami H; Kamiie J; Yasuno K; Kobayashi R; Aihara N; Shirota K
Nephrol Dial Transplant; 2012 Apr; 27(4):1324-30. PubMed ID: 21862459
[TBL] [Abstract][Full Text] [Related]
7. GLEPP1, a renal glomerular epithelial cell (podocyte) membrane protein-tyrosine phosphatase. Identification, molecular cloning, and characterization in rabbit.
Thomas PE; Wharram BL; Goyal M; Wiggins JE; Holzman LB; Wiggins RC
J Biol Chem; 1994 Aug; 269(31):19953-62. PubMed ID: 7519601
[TBL] [Abstract][Full Text] [Related]
8. Key molecular events in puromycin aminonucleoside nephrosis rats.
Guan N; Ding J; Deng J; Zhang J; Yang J
Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
[TBL] [Abstract][Full Text] [Related]
9. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
[TBL] [Abstract][Full Text] [Related]
10. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X
Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353
[TBL] [Abstract][Full Text] [Related]
11. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
[TBL] [Abstract][Full Text] [Related]
12. Early changes in gene expression that influence the course of primary glomerular disease.
Clement LC; Liu G; Perez-Torres I; Kanwar YS; Avila-Casado C; Chugh SS
Kidney Int; 2007 Aug; 72(3):337-47. PubMed ID: 17457373
[TBL] [Abstract][Full Text] [Related]
13. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
Kojima K; Matsui K; Nagase M
Am J Kidney Dis; 2000 Jun; 35(6):1175-85. PubMed ID: 10845833
[TBL] [Abstract][Full Text] [Related]
14. Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model.
Herrmann A; Tozzo E; Funk J
Exp Toxicol Pathol; 2012 Jan; 64(1-2):45-9. PubMed ID: 20591637
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between podocyte molecule's distribution and expression, foot process morphology and proteinuria].
Guan N; Deng JH; Ding J; Zhang JJ; Yang JY
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):139-44. PubMed ID: 15100730
[TBL] [Abstract][Full Text] [Related]
16. Reduced glomerular epithelial protein 1 expression and podocyte injury in immunoglobulin A nephropathy.
Tian J; Wang HP; Mao YY; Jin J; Chen JH
J Int Med Res; 2007; 35(3):338-45. PubMed ID: 17593862
[TBL] [Abstract][Full Text] [Related]
17. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat.
Kim YH; Goyal M; Kurnit D; Wharram B; Wiggins J; Holzman L; Kershaw D; Wiggins R
Kidney Int; 2001 Sep; 60(3):957-68. PubMed ID: 11532090
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
19. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of connexin43 in glomerular podocytes in response to injury.
Yaoita E; Yao J; Yoshida Y; Morioka T; Nameta M; Takata T; Kamiie J; Fujinaka H; Oite T; Yamamoto T
Am J Pathol; 2002 Nov; 161(5):1597-606. PubMed ID: 12414508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
